MedTrace Logo

Discontinuation of Antiretroviral Therapy in Patients With Asymptomatic HIV Infection

NCT00050284 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 158

Last updated 2010-11-09

No results posted yet for this study

Summary

The purpose of this study is to determine whether patients who have asymptomatic HIV infection can discontinue antiretroviral therapy (ART) without adverse clinical, virologic, or immunologic consequences. This study will also assess the virologic, immunologic, and clinical outcomes in any patients who restart ART.

Conditions

  • HIV Infections

Sponsors & Collaborators

  • National Institute of Allergy and Infectious Diseases (NIAID)

    lead NIH

Principal Investigators

  • Daniel J. Skiest, M. D. · University of Texas Southwestern Medical Center

Eligibility

Min Age
13 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00050284 on ClinicalTrials.gov